[et_pb_section fb_built=”1″ _builder_version=”4.10.5″ _module_preset=”default” custom_padding=”0px|||||” global_colors_info=”{}”][et_pb_row _builder_version=”4.10.5″ _module_preset=”default” custom_padding=”0px|||||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.10.5″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.10.5″ _module_preset=”default” global_colors_info=”{}”]
Seven technologies to watch in 2022
January 25, 2022 | Nature | Michael Einstein
Roughly one-tenth of the human genome remained uncharted when genomics researchers Karen Miga at the University of California, Santa Cruz, and Adam Phillippy at the National Human Genome Research Institute in Bethesda, Maryland, launched the Telomere-to-Telomere (T2T) consortium in 2019. Now, that number has dropped to zero. In a preprint published in May last year, the consortium reported the first end-to-end sequence of the human genome, adding nearly 200 million new base pairs to the widely used human consensus genome sequence known as GRCh38, and writing the final chapter of the Human Genome Project.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]